reference/33099871

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33099871

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	840
issn	2373-8227
issueIdentifier	6
pageRange	829-840
publicationName	ACS Infectious Diseases
startingPage	829
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0d6786c14e35ab0c92ab634e52de5d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e5b21b0e17980757c6b6505e1fad058d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_07a042575cee02af06e02e432b9b3809
bibliographicCitation	Wolf NM, Lee H, Choules MP, Pauli GF, Phansalkar R, Anderson JR, Gao W, Ren J, Santarsiero BD, Lee H, Cheng J, Jin YY, Ho NA, Duc NM, Suh JW, Abad-Zapatero C, Cho S. High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads. ACS Infect Dis. 2019 Jun 14;5(6):829–40. PMID: 30990022; PMCID: PMC6657506.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1771-3245 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1598b139918b94cfe3e0b21cc5dfe47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9055f23ee8b7319dfbd09a3f415c0f7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9032-9699 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e024737d9e2bc3d284dbf08be6ae7c90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57329bffc86a8b5c235fb708ec1cc91f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9664-1950 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79930f0efab13dd7d25212e913ae1ee3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f2617fbeff6b7506be87a3686c68415 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d3fe725853cdf5afd19410bda4f2e2c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25aed9bd761fa48a26196a723c2d0e8d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1022-4326 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4055499cb1af6fe8f09782ac6b66149 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91d3920316958fa148dc1d84af6bbf1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80f91c1b99c81f434e764f1a87afc8df http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0926-6246 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeeed582a458e52c47104f2a0576a889
date	2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1021/acsinfecdis.8b00276 https://pubmed.ncbi.nlm.nih.gov/30990022 https://pubmed.ncbi.nlm.nih.gov/PMC6657506
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43689 https://portal.issn.org/resource/ISSN/2373-8227
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads
discusses	http://id.nlm.nih.gov/mesh/M000654237 http://id.nlm.nih.gov/mesh/M0001515 http://id.nlm.nih.gov/mesh/M0009986 http://id.nlm.nih.gov/mesh/M0015279 http://id.nlm.nih.gov/mesh/M0002130 http://id.nlm.nih.gov/mesh/M0012508 http://id.nlm.nih.gov/mesh/M0528160
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009842Q000737 http://id.nlm.nih.gov/mesh/D000995Q000737 http://id.nlm.nih.gov/mesh/D009169Q000187 http://id.nlm.nih.gov/mesh/D001426Q000737 http://id.nlm.nih.gov/mesh/D006360Q000737
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000995Q000494 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D015195 http://id.nlm.nih.gov/mesh/D009842Q000494 http://id.nlm.nih.gov/mesh/D000072417 http://id.nlm.nih.gov/mesh/D008826 http://id.nlm.nih.gov/mesh/D008024 http://id.nlm.nih.gov/mesh/D001665 http://id.nlm.nih.gov/mesh/D018360 http://id.nlm.nih.gov/mesh/D009169Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10772429 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76871757 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4345fc0be47d067afdd7af0e9b2f32d7 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324616 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9505 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362487 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4901a3b2f9e18cd46dd0ba9db43f7956 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101894301 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1742210

Total number of triples: 70.